Data from DNA-PK Inhibition Shows Differential Radiosensitization in Orthotopic GBM PDX Models Based on DDR Pathway Deficits
Sonja Dragojevic(Mayo Clinic in Arizona), Cameron M. Callaghan(Mayo Clinic in Arizona), Emily J. Smith(WinnMed), Lauren L. Ott(WinnMed), Jann N. Sarkaria(Mayo Clinic in Arizona), Daniel J. Laverty(Massachusetts Department of Public Health), Zhiyi Xue(Mayo Clinic), William F. Elmquist(University of Minnesota), Danielle M. Burgenske(Mayo Clinic in Arizona), Jeanette E. Eckel‐Passow(Mayo Clinic in Florida), Shiv K. Gupta(Mayo Clinic), Brett L. Carlson(University of California, San Francisco), Nathalie Y.R. Agar(Texas Endosurgery Institute), Gerard Baquer(Center for Pain and the Brain), Sylwia A. Stopka(Brigham and Women's Hospital), Paul A. Decker(University of California, San Francisco), Margaret A. Connors(Mayo Clinic), Michael S. Regan(Brigham and Women's Hospital), Zachary D. Nagel(Harvard University), Zeng Hu(Mayo Clinic), Wenjuan Zhang(Sanming University), Jake A. Kloeber(Mayo Clinic in Arizona), Shulan Tian(Mayo Clinic), Katrina K. Bakken(Mayo Clinic in Arizona)
Cited by 0
Related Papers
Rapid, Label-Free Detection of Brain Tumors with Stimulated Raman Scattering Microscopy
|Science Translational Medicine|2013|510
Induction of MGMT expression is associated with temozolomide resistance in glioblastoma xenografts
|Neuro-Oncology|2008|387
Genome-wide association study of glioma subtypes identifies specific differences in genetic susceptibility to glioblastoma and non-glioblastoma tumors
|Nature Genetics|2017|381
Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors
|Proceedings of the National Academy of Sciences|2013|288